Overview of NICE’s Elranatamab Managed Ac...

By João L. Carapinha

October 29, 2024

NICE recently recommended Elranatamab as an option for treating relapsed and refractory multiple myeloma in adults with a man...
Ozempic Shows Promise in Reducing Alzheimer’s Risk
Rifaximin Use Linked to Daptomycin Resistance: Implications for Antibiotic St...
CTO-PCI Technology for Heart Health in Egypt
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
Mental Healthcare for Youth: Addressing Substance Use and Chronic Conditions
Depression and Life Satisfaction in Pregnant Women
The VA’s Journey with Early Adoption of AI in Healthcare
Internet Use and Adolescent Mental Health: The Role of Parental Support
Boosting HPV Cervical Cancer Awareness: Key Insights on Public Survey
Enhancing Global Health through Regulatory Collaboration